MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Rapid eye movement(REM)"

  • 2018 International Congress

    Tracking RBD and PD progression with longitudinal structural brain connectomes

    J. Suescun, O. Peña Nogales, T. Ellmore, R. de Luis-Garcia, M. Schiess, L. Giancardo (Houston, TX, USA)

    Objective: To compare longitudinal structural connectomes derived from whole brain dMRI and PD clinical rating scales as a disease progression biomarker, on three cohorts: de-novo…
  • 2018 International Congress

    Free-living gait in REM sleep behaviour disorder: Measures of prodromal Parkinson’s disease?

    S. Del Din, T. Barber, C. Lo, M. Rolinski, F. Baig, M. Hu, L. Rochester (Newcastle upon Tyne, United Kingdom)

    Objective: The aim of this study was to investigate if free-living gait monitoring can discriminate individuals with REM sleep behaviour disorder (RBD) from controls. Background:…
  • 2018 International Congress

    Polysomnographic data in Dementia with Lewy Bodies: Correlation with clinical features and comparison with other alfa-synucleinopathies

    P. Bugalho, M. Salavisa, J. Marto, C. Borbinha, L. Alves (Lisbon, Portugal)

    Objective: 1) Polysomnography (PSG) assessment of sleep in Dementia with Lewy Bodies (DLB). 2) Correlation between PSG data, fluctuations and hypersomnolence. 3) Comparison of PSG…
  • 2018 International Congress

    Comparisons of cerebral glucose metabolism and striatal DAT binding in PD patients with and without RBD

    P. Wu, Q. Xu, J. Wang, C. Zuo (Shanghai, China)

    Objective: This study aims to identify the differences of functional neuroimaging phenotype between Parkinson’s disease (PD) patients with REM sleep behavior disorder (RBD) (PD+RBD+) and…
  • 2018 International Congress

    Preliminary evidence for an altered relationship between uric acid levels and resting state functional connectivity in REM sleep behavior disorder

    M. Schiess, J. Suescun, L. Giancardo, R. Castriotta, T. Ellmore (Houston, TX, USA)

    Objective: To determine the relationship between uric acid (UA) levels and functional connectivity in REM sleep behavior disorder (RBD) compared to controls. Background: UA levels…
  • 2018 International Congress

    Diminished fMRI global signal differences between eyes closed and eyes open resting state in RBD and PD

    J. Suescun, M. Schiess, L. Giancardo, R. Castriotta, T. Ellmore (Houston, TX, USA)

    Objective: test whether patients with Parkinson’s diseases (PD) and REM sleep behavior disorder (RBD) exhibit diminished state-related changes in their resting state fMRI global signal.…
  • 2018 International Congress

    Exploring the neural correlates of gait asymmetry in idiopathic REM Sleep Behaviour Disorder

    K. Ehgoetz Martens, E. Matar, J. Hall, M. Georgiades, M. Gilat, J. Shine, S. Lewis (Camperdown, Australia)

    Objective: Given the typical asymmetric onset of motor symptoms in PD, the current study sought to investigate whether patients with iRBD show evidence of asymmetric…
  • 2018 International Congress

    In vivo staging of pathology in REM sleep behaviour disorder

    K. Knudsen, T. Fedorova, A. Hansen, M. Sommerauer, M. Otto, K. Svendsen, A. Nahimi, M. Stokholm, N. Pavese, C. Beier, D. Brooks, P. Borghammer (Aarhus, Denmark)

    Objective: To study the level of dysfunction in the peripheral and central nervous system in idiopathic REM sleep behaviour disorder (iRBD) patients. Background: α-synuclein (α-syn)…
  • 2018 International Congress

    Efficacy of prolonged release melatonin for REM sleep behaviour disorder in Parkinson’s disease: A double blind, randomised, placebo-controlled trial

    M. Gilat, R. Grunstein, N. Marshall, D. Hammond, A. Coeytaux Jackson, A. Mullins, J. Hall, S. (Sydney, Australia)

    Objective: Test the efficacy of prolonged-released melatonin for REM sleep behaviour disorder (RBD) in Parkinson’s disease (PD). Background: Half of all PD patients experience RBD…
  • 2018 International Congress

    Temporal evolution of biomarkers from healthy ageing, isolated REM sleep behavior to early Parkinson’s disease

    B. Mollenhauer, M-L. Muntean, J. Zimmermann, K. Focke, T. Wicke, J. Ebentheuer, M. Schaumburg, E. Lang, WH. Oertel, F. Sixel-Döring, C. Trenkwalder (Kassel, Germany)

    Objective: To study the temporal evolution of biomarkers of various modalities in healthy ageing controls (HC), the prodromal condition of isolated REM sleep behavior disorder…
  • « Previous Page
  • 1
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • …
  • 20
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley